Atomi Financial Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$603K Buy
2,792
+50
+2% +$9.56K 0.02% 684
2026
Q1
$503K Sell
2,742
-536
-16% -$98.8K 0.02% 712
2025
Q4
$577K Buy
+3,278
New +$536K 0.02% 626
2025
Q3
Sell
-1,800
Closed -$226K 1172
2025
Q2
$226K Buy
+1,800
New +$224K 0.01% 985

Other funds holding BIIB

Atomi Financial Group's BIIB Position: Q2 2026 in Review

Atomi Financial Group increased its Biogen (BIIB) stake by 1.8% in Q2 2026, buying an estimated $9.56K and bringing the position to 2,792 shares worth $603K. The position accounts for 0.02% of the portfolio, ranked #684.

Atomi Financial Group first reported a position in BIIB in Q2 2025 and has held it in 4 quarters since. 1,045 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Atomi Financial Group held 2,792 shares of Biogen worth $603K as of Q2 2026.
  • Atomi Financial Group bought 50 Biogen shares in Q2 2026, an estimated $9.56K.
  • Biogen made up 0.02% of Atomi Financial Group's portfolio in Q2 2026, its #684 holding.
  • Atomi Financial Group first reported a position in Biogen in Q2 2025 and has held it in 4 quarters since.
  • 1,045 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.